ÂÜÀòÂÒÂ×

Baha Yaghmour is an experienced professional specializing in upstream bioprocessing, with a focus on AAV vector production across various bioreactor platforms. Currently serving as an Account Manager for Bioprocess Solutions at Sartorius Stedim Biotech since May 2024, Baha previously held the position of Expert in Science & Technology at Novartis Gene Therapies, contributing to the acquisition of Gyroscope Therapeutics. Baha's background includes roles at Gyroscope Therapeutics as a Process Development Associate and Research Associate, as well as research positions at King's College London, UK Biocentre, Uppsala University Hospital, and Umeå University, encompassing a wide range of molecular biology and genomic projects. Educational qualifications include a Master's degree in Molecular Biology from Uppsala University and a Bachelor's degree in Biotechnology and Genetic Engineering from Jordan University of Science and Technology.